Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis-Reference-Cited by-同舟云学术

Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis

Published:2022-11 Issue:11 Volume:9 Page:e751-e759
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Macleod David,Shanaube Kwame,Skalland Timothy,Limbada Mohammed,Mandla Nomtha,Bwalya Justin,Schaap Ab,Yang Blia,Donnell Deborah,Piwowar-Manning Estelle,Eshleman Susan H,Hoddinott Graeme,Bond Virginia,Moore Ayana,Griffith Sam,Bock Peter,Ayles Helen,Fidler Sarah,Hayes Richard,Floyd Sian

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference21 articles.

1. A trial of early antiretrovirals and isoniazid preventive therapy in Africa;Danel;N Engl J Med,2015

2. Initiation of antiretroviral therapy in early asymptomatic HIV infection;Lundgren;N Engl J Med,2015

3. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations;Haberer;J Int AIDS Soc,2017

4. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings;Scanlon;HIV AIDS,2013

5. Retention in care and adherence to ART are critical elements of HIV care interventions;Stricker;AIDS Behav,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV viral suppression in the era of dolutegravir use: Findings from a national survey in Tanzania;PLOS ONE;2024-08-14

2. Changes in access to viral load testing, incidence rates of viral load suppression and rebound following the introduction of the ‘universal test and treat’ guidelines in Cameroon: A retrospective follow-up analysis;PLOS Global Public Health;2024-04-16

3. “What if I got rejected by the girl? I would rather stop the pills”: barriers and facilitators of adherence to antiretroviral therapy for emerging adults aged 18–29 living with HIV in Zimbabwe;AIDS Care;2024-03-27

4. Lessons from the HPTN 071 (PopART) trial;The Lancet HIV;2022-11

5. Effect of UTT on viral suppression and ART adherence;The Lancet HIV;2022-11